Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Mark Boguniewicz

Concepts (542)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dermatitis, Atopic
169
2026
321
25.200
 Why?
Antibodies, Monoclonal, Humanized
25
2026
985
3.130
 Why?
Eczema
14
2023
66
2.910
 Why?
Severity of Illness Index
53
2026
2925
2.150
 Why?
Antibodies, Monoclonal
10
2025
1519
2.040
 Why?
Skin
34
2024
755
1.780
 Why?
Tacrolimus
20
2023
196
1.630
 Why?
Biological Products
3
2024
252
1.620
 Why?
Asthma
19
2025
1767
1.530
 Why?
Pruritus
17
2026
59
1.480
 Why?
Dermatologic Agents
14
2024
68
1.390
 Why?
Quality of Life
31
2025
3185
1.380
 Why?
Staphylococcus aureus
15
2024
455
1.320
 Why?
Practice Guidelines as Topic
11
2025
1560
1.270
 Why?
Staphylococcal Skin Infections
8
2018
41
1.230
 Why?
Immunosuppressive Agents
15
2024
846
1.210
 Why?
Double-Blind Method
29
2025
2029
1.100
 Why?
Keratinocytes
12
2024
248
1.010
 Why?
Receptors, Aryl Hydrocarbon
2
2024
60
0.990
 Why?
Calcineurin Inhibitors
14
2010
69
0.880
 Why?
Immunoglobulin E
19
2024
315
0.860
 Why?
Humans
188
2026
144759
0.860
 Why?
Kaposi Varicelliform Eruption
12
2013
21
0.860
 Why?
Treatment Outcome
35
2026
11679
0.720
 Why?
Cytokines
17
2024
2061
0.690
 Why?
Administration, Topical
17
2026
150
0.690
 Why?
Boron Compounds
3
2018
29
0.690
 Why?
Urticaria
3
2008
38
0.670
 Why?
Hypersensitivity
3
2023
252
0.670
 Why?
Emollients
4
2018
11
0.670
 Why?
Interleukin-4 Receptor alpha Subunit
1
2020
9
0.660
 Why?
Adrenal Cortex Hormones
11
2023
478
0.650
 Why?
Intermediate Filament Proteins
7
2018
57
0.640
 Why?
Janus Kinase Inhibitors
3
2025
28
0.630
 Why?
Bridged Bicyclo Compounds, Heterocyclic
3
2018
279
0.590
 Why?
Allergy and Immunology
2
2017
42
0.590
 Why?
Bandages
3
2016
42
0.590
 Why?
Dermatology
3
2017
128
0.580
 Why?
Anti-Infective Agents
5
2022
242
0.580
 Why?
Expert Testimony
1
2019
42
0.570
 Why?
Anti-Inflammatory Agents
11
2020
474
0.560
 Why?
Adult
77
2025
40449
0.550
 Why?
Skin Care
4
2008
25
0.550
 Why?
Interleukin-13
11
2025
144
0.550
 Why?
Antimicrobial Cationic Peptides
6
2010
86
0.540
 Why?
Food Hypersensitivity
6
2024
164
0.540
 Why?
Interferon-gamma
11
2013
784
0.540
 Why?
Biological Therapy
1
2017
28
0.530
 Why?
Occlusive Dressings
1
2016
7
0.500
 Why?
Psoriasis
12
2023
112
0.490
 Why?
Aminopyridines
3
2026
127
0.490
 Why?
Anti-Asthmatic Agents
1
2019
251
0.480
 Why?
Benzamides
3
2026
224
0.480
 Why?
Interleukin-4
9
2023
206
0.470
 Why?
Phosphodiesterase 4 Inhibitors
2
2026
12
0.460
 Why?
Herpes Simplex
3
2013
98
0.460
 Why?
Comorbidity
8
2025
1658
0.450
 Why?
Child, Preschool
34
2026
11787
0.450
 Why?
Advisory Committees
1
2017
228
0.450
 Why?
Desensitization, Immunologic
5
2024
89
0.440
 Why?
Education, Medical, Continuing
1
2016
132
0.430
 Why?
Epidermis
3
2017
157
0.430
 Why?
Cost of Illness
9
2018
321
0.420
 Why?
beta-Defensins
8
2010
22
0.410
 Why?
Adolescent
39
2025
22428
0.410
 Why?
Simplexvirus
3
2011
82
0.410
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
3
2018
15
0.410
 Why?
Glycyrrhetinic Acid
3
2008
7
0.400
 Why?
Conjunctivitis
3
2023
30
0.400
 Why?
Th2 Cells
6
2017
171
0.400
 Why?
Child
44
2024
22633
0.400
 Why?
Anti-Allergic Agents
3
2014
40
0.390
 Why?
Administration, Cutaneous
10
2026
125
0.390
 Why?
Molecular Targeted Therapy
2
2020
432
0.380
 Why?
Hypersensitivity, Immediate
3
2019
40
0.380
 Why?
Autoimmune Diseases
4
2018
463
0.380
 Why?
Calcineurin
5
2006
105
0.370
 Why?
Histamine H1 Antagonists
3
2026
24
0.360
 Why?
Male
60
2026
72315
0.360
 Why?
Immunity, Innate
6
2011
846
0.330
 Why?
Allergens
7
2023
384
0.330
 Why?
Anti-Inflammatory Agents, Non-Steroidal
4
2015
338
0.330
 Why?
Histamine Antagonists
2
2026
20
0.330
 Why?
Female
58
2026
78271
0.320
 Why?
Drug Approval
3
2020
89
0.320
 Why?
Ointments
10
2016
25
0.320
 Why?
Adaptive Immunity
1
2011
169
0.310
 Why?
Plant Extracts
3
2008
187
0.310
 Why?
Clinical Trials as Topic
4
2020
1053
0.300
 Why?
Infant
24
2024
10034
0.300
 Why?
Complementary Therapies
1
2010
94
0.300
 Why?
Staphylococcal Infections
4
2023
388
0.290
 Why?
Dietary Fats
2
2008
314
0.290
 Why?
Off-Label Use
2
2020
49
0.290
 Why?
Methicillin-Resistant Staphylococcus aureus
1
2012
248
0.290
 Why?
Disease Progression
6
2019
2847
0.290
 Why?
Drug Hypersensitivity
3
1995
90
0.290
 Why?
Receptors, IgE
1
2008
43
0.280
 Why?
Population Groups
2
2018
58
0.280
 Why?
Chronic Disease
12
2019
1813
0.270
 Why?
Prevalence
12
2019
2834
0.270
 Why?
Middle Aged
39
2025
35875
0.260
 Why?
Biomarkers
8
2024
4271
0.260
 Why?
Inflammation
4
2018
2878
0.260
 Why?
Disease Management
5
2020
645
0.260
 Why?
Self Report
7
2019
872
0.260
 Why?
Pyrimidines
4
2024
532
0.250
 Why?
United States
20
2024
15966
0.250
 Why?
Sulfonamides
4
2023
580
0.250
 Why?
Rhinitis, Allergic
2
2024
42
0.240
 Why?
Chemokine CCL17
2
2024
5
0.240
 Why?
Consensus
3
2024
488
0.230
 Why?
Dermatitis, Allergic Contact
2
2016
72
0.220
 Why?
Cross-Sectional Studies
14
2021
5868
0.220
 Why?
Patch Tests
3
2016
57
0.220
 Why?
Vaccinia virus
4
2011
34
0.220
 Why?
Anti-Bacterial Agents
6
2023
1907
0.220
 Why?
Omalizumab
2
2020
43
0.220
 Why?
Sphingosine N-Acyltransferase
1
2024
6
0.220
 Why?
Phototherapy
3
2018
48
0.220
 Why?
Steroids
3
2017
160
0.210
 Why?
Exanthema
1
2005
84
0.210
 Why?
Diagnosis, Differential
7
2008
1489
0.210
 Why?
Ectropion
1
2023
1
0.200
 Why?
Pyrazoles
2
2024
509
0.200
 Why?
Randomized Controlled Trials as Topic
7
2026
1720
0.200
 Why?
Janus Kinases
1
2023
20
0.200
 Why?
Pain
2
2019
779
0.200
 Why?
Down-Regulation
7
2017
627
0.200
 Why?
Membrane Proteins
5
2024
1166
0.200
 Why?
Blepharitis
1
2023
9
0.190
 Why?
Drug Administration Schedule
6
2026
779
0.190
 Why?
Young Adult
13
2025
14105
0.190
 Why?
Sublingual Immunotherapy
1
2022
4
0.190
 Why?
Anxiety
3
2019
1109
0.190
 Why?
Drug Industry
2
2018
49
0.190
 Why?
Receptors, Interleukin
3
2020
43
0.190
 Why?
Animals
17
2024
38058
0.180
 Why?
Tight Junctions
3
2011
81
0.180
 Why?
Sickness Impact Profile
2
2019
62
0.180
 Why?
Cefuroxime
1
2001
5
0.180
 Why?
Cyclopropanes
3
2026
83
0.170
 Why?
Recurrence
4
2019
1135
0.170
 Why?
Skin Cream
3
2026
11
0.170
 Why?
Cephalosporins
1
2001
47
0.170
 Why?
STAT6 Transcription Factor
3
2011
24
0.170
 Why?
Autoantibodies
1
2008
1501
0.160
 Why?
Evidence-Based Medicine
3
2024
732
0.160
 Why?
Depression
3
2019
1558
0.160
 Why?
Bacterial Toxins
3
2012
109
0.160
 Why?
Patient Education as Topic
5
2015
780
0.160
 Why?
Patient Reported Outcome Measures
5
2024
488
0.160
 Why?
Injections, Subcutaneous
4
2023
164
0.150
 Why?
Sleep Initiation and Maintenance Disorders
1
2022
194
0.150
 Why?
Skin Diseases, Infectious
3
2008
13
0.150
 Why?
Vaccines
1
2024
389
0.150
 Why?
Phosphodiesterase Inhibitors
1
2018
73
0.140
 Why?
Patient Health Questionnaire
1
2018
41
0.140
 Why?
Injections
1
2019
196
0.140
 Why?
Gene Expression Regulation
7
2011
2608
0.130
 Why?
Genetic Predisposition to Disease
6
2011
2363
0.130
 Why?
Immunologic Factors
2
2005
255
0.130
 Why?
Surveys and Questionnaires
5
2019
6048
0.130
 Why?
Guidelines as Topic
2
2018
267
0.130
 Why?
Skin Diseases
1
2019
149
0.130
 Why?
T-Lymphocytes
6
2006
1982
0.130
 Why?
Sleep Wake Disorders
1
2021
301
0.130
 Why?
Skin Diseases, Viral
2
2018
6
0.120
 Why?
Drug Therapy, Combination
4
2026
1047
0.120
 Why?
Gloves, Surgical
1
1996
4
0.120
 Why?
Latex
1
1996
9
0.120
 Why?
Rubber
1
1996
7
0.120
 Why?
Gloves, Protective
1
1996
3
0.120
 Why?
Personal Satisfaction
1
2018
222
0.120
 Why?
Practice Patterns, Physicians'
2
2017
1356
0.120
 Why?
Cells, Cultured
13
2011
4154
0.120
 Why?
Dermatitis, Occupational
1
1996
16
0.120
 Why?
Bronchial Hyperreactivity
1
1996
96
0.120
 Why?
Chemokines, CC
3
2006
32
0.120
 Why?
Receptors, Cytokine
2
2010
36
0.110
 Why?
Milk Proteins
1
2015
35
0.110
 Why?
Milk Hypersensitivity
1
2015
18
0.110
 Why?
T-Lymphocyte Subsets
2
2011
415
0.110
 Why?
Patient Acceptance of Health Care
2
2019
885
0.110
 Why?
Primary Health Care
2
2016
1733
0.110
 Why?
Infant Formula
1
2015
71
0.110
 Why?
Hydrotherapy
1
2014
7
0.110
 Why?
Patient-Centered Care
2
2018
544
0.110
 Why?
Clinical Decision-Making
1
2018
359
0.100
 Why?
Skin Tests
3
2012
94
0.100
 Why?
Patient Care Planning
1
2015
169
0.100
 Why?
Gene Expression Profiling
4
2011
1782
0.100
 Why?
Ambulatory Care
1
2019
600
0.100
 Why?
HLA-B7 Antigen
1
2013
7
0.100
 Why?
Recombinant Proteins
6
2006
1370
0.100
 Why?
Dose-Response Relationship, Drug
5
2020
2027
0.100
 Why?
Algorithms
3
2018
1837
0.100
 Why?
Clinical Trials, Phase III as Topic
2
2024
117
0.100
 Why?
Risk Factors
8
2015
10779
0.100
 Why?
Cholecalciferol
1
2013
60
0.090
 Why?
Health Status
1
2018
836
0.090
 Why?
Logistic Models
4
2019
2117
0.090
 Why?
Delphi Technique
2
2024
329
0.090
 Why?
Lipids
1
2017
710
0.090
 Why?
RNA, Messenger
10
2007
2832
0.090
 Why?
Interferon Regulatory Factor-2
1
2011
3
0.090
 Why?
Vitamins
1
2013
178
0.090
 Why?
Eosinophils
3
2024
316
0.090
 Why?
Aged
13
2019
25913
0.090
 Why?
Immunity, Cellular
1
2013
272
0.090
 Why?
Fibronectins
2
2023
136
0.090
 Why?
Research Design
1
2018
1135
0.090
 Why?
Vitamin D
2
2013
400
0.090
 Why?
Mice, Transgenic
3
2011
2182
0.080
 Why?
Polymorphism, Single Nucleotide
7
2011
2145
0.080
 Why?
Physical Therapy Modalities
1
2014
332
0.080
 Why?
Pharmaceutical Vehicles
2
2008
12
0.080
 Why?
Guideline Adherence
1
2015
589
0.080
 Why?
Glucocorticoids
2
2013
535
0.080
 Why?
Th1-Th2 Balance
1
2010
8
0.080
 Why?
JNK Mitogen-Activated Protein Kinases
1
2011
153
0.080
 Why?
CD4-Positive T-Lymphocytes
3
2010
1129
0.080
 Why?
Signal Transduction
2
2023
5226
0.080
 Why?
Receptors, Chemokine
1
2010
47
0.080
 Why?
Chickenpox Vaccine
1
2010
75
0.080
 Why?
Therapies, Investigational
1
2010
18
0.080
 Why?
Receptors, Interleukin-7
1
2010
28
0.080
 Why?
Cathelicidins
5
2010
41
0.080
 Why?
Hypertension
1
2018
1263
0.080
 Why?
Herpesviridae Infections
1
2010
150
0.070
 Why?
Genetic Variation
2
2011
983
0.070
 Why?
Cardiovascular Diseases
2
2018
2168
0.070
 Why?
Adjuvants, Immunologic
3
2004
245
0.070
 Why?
Age Factors
4
2019
3333
0.070
 Why?
Oligonucleotide Array Sequence Analysis
3
2011
758
0.070
 Why?
Coal Tar
1
2008
2
0.070
 Why?
Keratolytic Agents
1
2008
5
0.070
 Why?
Dietary Supplements
1
2013
576
0.070
 Why?
Pediatrics
2
2015
1114
0.070
 Why?
Cell Degranulation
1
2008
42
0.070
 Why?
Mice
9
2012
18339
0.070
 Why?
Disease Outbreaks
1
2012
422
0.070
 Why?
Pyroglyphidae
2
2022
18
0.070
 Why?
Irritants
1
2008
38
0.070
 Why?
Polymorphism, Genetic
1
2011
612
0.070
 Why?
Basophils
1
2008
52
0.070
 Why?
S100 Proteins
1
2008
36
0.070
 Why?
Dosage Forms
1
2008
10
0.070
 Why?
Tumor Necrosis Factor-alpha
2
2011
1217
0.070
 Why?
Phenotype
4
2023
3162
0.070
 Why?
United Kingdom
2
2019
338
0.070
 Why?
Aged, 80 and over
6
2019
8265
0.070
 Why?
Environmental Exposure
1
2012
588
0.070
 Why?
Combined Modality Therapy
3
2014
1266
0.060
 Why?
Reference Values
2
2019
797
0.060
 Why?
CD8-Positive T-Lymphocytes
1
2013
917
0.060
 Why?
Protein Precursors
1
2007
137
0.060
 Why?
Herpesvirus 3, Human
1
2010
336
0.060
 Why?
Macrophage Inflammatory Proteins
1
2006
11
0.060
 Why?
Mast Cells
1
2008
146
0.060
 Why?
Immunohistochemistry
6
2010
1716
0.060
 Why?
Clinical Protocols
1
2008
282
0.060
 Why?
Quality Improvement
1
2016
1289
0.060
 Why?
Cromolyn Sodium
1
2026
6
0.060
 Why?
Disease Susceptibility
2
2020
348
0.060
 Why?
Drug Combinations
3
2020
390
0.060
 Why?
Patient Dropouts
1
2007
65
0.060
 Why?
Emergency Service, Hospital
1
2019
2310
0.060
 Why?
Nonprescription Drugs
1
2007
65
0.060
 Why?
Cost-Benefit Analysis
3
2018
634
0.060
 Why?
Lymphocyte Activation
3
2010
1126
0.060
 Why?
Antibodies, Anti-Idiotypic
1
2006
51
0.060
 Why?
Receptors, Lymphocyte Homing
1
2006
15
0.060
 Why?
Virus Replication
2
2006
529
0.060
 Why?
Proteins
2
2010
1021
0.060
 Why?
Gene Frequency
3
2013
481
0.060
 Why?
Conjunctivitis, Allergic
1
2025
4
0.060
 Why?
Immunoglobulins
2
2005
160
0.060
 Why?
Thiazoles
1
2006
135
0.060
 Why?
Thyroid Diseases
1
2005
43
0.050
 Why?
Models, Immunological
1
2005
100
0.050
 Why?
L-Lactate Dehydrogenase
1
2024
115
0.050
 Why?
Interleukins
1
2006
248
0.050
 Why?
Academies and Institutes
1
2004
60
0.050
 Why?
Resorcinols
1
2023
5
0.050
 Why?
Immunoglobulin G
2
2023
893
0.050
 Why?
Conflict of Interest
1
2004
52
0.050
 Why?
Hyaluronic Acid
1
2006
208
0.050
 Why?
Stilbenes
1
2023
33
0.050
 Why?
Lactams
2
1995
28
0.050
 Why?
Statistics, Nonparametric
2
2019
427
0.050
 Why?
Gene Expression
4
2007
1490
0.050
 Why?
Interleukin-10
1
2005
309
0.050
 Why?
Janus Kinase 1
1
2023
26
0.050
 Why?
Leukocyte Count
2
1995
316
0.050
 Why?
Nitriles
1
2024
205
0.050
 Why?
Interleukin-11
1
2003
10
0.050
 Why?
STAT Transcription Factors
1
2023
24
0.050
 Why?
Acute Disease
6
2008
1030
0.050
 Why?
Membrane Glycoproteins
1
2006
496
0.050
 Why?
Risk
2
2018
911
0.050
 Why?
Prednisone
2
1994
221
0.050
 Why?
Dermatophagoides pteronyssinus
1
2022
3
0.050
 Why?
Patient Compliance
1
2007
588
0.050
 Why?
Patient Care Team
1
2008
689
0.050
 Why?
Azetidines
1
2022
45
0.050
 Why?
Respiratory Sounds
1
2023
105
0.050
 Why?
Clinical Trials, Phase II as Topic
1
2022
77
0.050
 Why?
Interleukin-17
1
2003
118
0.050
 Why?
Granuloma, Respiratory Tract
1
2002
13
0.050
 Why?
Insurance, Physician Services
1
2002
4
0.050
 Why?
Baths
1
2022
13
0.050
 Why?
Leukocytes, Mononuclear
3
2013
573
0.050
 Why?
Langerhans Cells
1
2001
12
0.040
 Why?
3',5'-Cyclic-AMP Phosphodiesterases
1
2001
8
0.040
 Why?
Prognosis
3
2018
4282
0.040
 Why?
Lymphoma
2
2018
232
0.040
 Why?
North America
1
2022
310
0.040
 Why?
Superantigens
1
2001
70
0.040
 Why?
Ceramides
1
2022
116
0.040
 Why?
Purines
1
2022
187
0.040
 Why?
Prospective Studies
2
2020
7990
0.040
 Why?
Interleukin-15
1
2002
97
0.040
 Why?
Immunotherapy
1
2006
653
0.040
 Why?
Claudin-1
2
2011
15
0.040
 Why?
Prodrugs
1
2001
52
0.040
 Why?
Time Factors
2
2007
7173
0.040
 Why?
Beryllium
1
2002
161
0.040
 Why?
Antigens, Bacterial
1
2001
125
0.040
 Why?
Bacterial Adhesion
1
2001
109
0.040
 Why?
Placebos
1
2021
192
0.040
 Why?
Caregivers
2
2023
1049
0.040
 Why?
Monocyte Chemoattractant Proteins
1
2000
7
0.040
 Why?
Diet
2
2022
1273
0.040
 Why?
Disease Models, Animal
1
2011
4557
0.040
 Why?
Bayes Theorem
1
2022
433
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
3
2011
851
0.040
 Why?
Fibrinogen
1
2001
177
0.040
 Why?
Health Expenditures
1
2002
194
0.040
 Why?
Longitudinal Studies
2
2019
2947
0.040
 Why?
Injection Site Reaction
1
2020
3
0.040
 Why?
Markov Chains
2
2015
129
0.040
 Why?
Chemokines, CXC
2
2003
68
0.040
 Why?
Leg Dermatoses
1
2019
1
0.040
 Why?
Scalp Dermatoses
1
2019
4
0.040
 Why?
Foot Dermatoses
1
2019
4
0.040
 Why?
Buttocks
1
2019
14
0.040
 Why?
Hand Dermatoses
1
2019
7
0.040
 Why?
Facial Dermatoses
1
2019
17
0.040
 Why?
Bronchoalveolar Lavage Fluid
3
2002
636
0.040
 Why?
Biopsy
4
2007
1075
0.040
 Why?
Fatty Acids
1
2022
450
0.040
 Why?
Genitalia
1
2019
34
0.040
 Why?
Genetic Association Studies
2
2011
372
0.040
 Why?
Risk Assessment
2
2019
3671
0.040
 Why?
Smallpox Vaccine
2
2011
23
0.040
 Why?
Interleukin-16
1
1998
6
0.040
 Why?
Haplotypes
2
2011
490
0.040
 Why?
Torso
1
2019
36
0.040
 Why?
Skin Diseases, Bacterial
1
2018
22
0.040
 Why?
Infection Control
1
2020
172
0.040
 Why?
Autoantigens
1
2001
429
0.040
 Why?
Dysbiosis
1
2020
187
0.040
 Why?
Association
1
2018
12
0.040
 Why?
Thalidomide
1
2018
43
0.040
 Why?
Acetamides
1
2018
37
0.040
 Why?
Rhinitis, Allergic, Seasonal
1
2018
25
0.040
 Why?
Arm
1
2019
109
0.030
 Why?
Phthalic Acids
1
2018
51
0.030
 Why?
Canada
1
2020
428
0.030
 Why?
Colony Count, Microbial
1
2018
122
0.030
 Why?
Herpesvirus 2, Human
2
2009
27
0.030
 Why?
Age Distribution
1
2018
403
0.030
 Why?
Sex Distribution
1
2018
386
0.030
 Why?
Medicaid
1
2002
461
0.030
 Why?
Fundoplication
1
1997
54
0.030
 Why?
Immune System
1
2018
179
0.030
 Why?
Quinazolines
1
2018
266
0.030
 Why?
United States Food and Drug Administration
1
2018
203
0.030
 Why?
Peak Expiratory Flow Rate
2
1993
25
0.030
 Why?
Psychiatric Status Rating Scales
1
2019
541
0.030
 Why?
Monocytes
2
2002
538
0.030
 Why?
Pilot Projects
2
1995
1886
0.030
 Why?
Educational Status
1
2019
467
0.030
 Why?
Forced Expiratory Volume
2
1997
449
0.030
 Why?
Texas
2
2008
278
0.030
 Why?
Proteomics
1
2023
1195
0.030
 Why?
Interleukin-12
1
1996
117
0.030
 Why?
Health Occupations
1
1996
36
0.030
 Why?
Genetic Linkage
1
1996
273
0.030
 Why?
Whey Proteins
1
2015
9
0.030
 Why?
Vaccination
1
2024
1423
0.030
 Why?
Psychometrics
1
2019
734
0.030
 Why?
Penicillins
1
1995
61
0.030
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
983
0.030
 Why?
Multivariate Analysis
1
2019
1539
0.030
 Why?
Gastroesophageal Reflux
1
1997
236
0.030
 Why?
Legionellosis
1
1994
2
0.030
 Why?
Legionnaires' Disease
1
1994
4
0.030
 Why?
Nebulizers and Vaporizers
1
1995
62
0.030
 Why?
Dermatitis, Irritant
2
2004
9
0.030
 Why?
Anaphylaxis
1
1996
102
0.030
 Why?
Intraoperative Complications
1
1996
155
0.030
 Why?
Milk
1
2015
119
0.030
 Why?
Polymerase Chain Reaction
2
2010
1054
0.030
 Why?
Pneumonia, Pneumocystis
1
1994
34
0.030
 Why?
Methylprednisolone
1
1994
64
0.030
 Why?
Pyridines
1
2018
605
0.030
 Why?
Feasibility Studies
1
2018
1095
0.030
 Why?
Socioeconomic Factors
1
2019
1326
0.030
 Why?
Attention Deficit Disorder with Hyperactivity
1
2018
428
0.030
 Why?
Long-Term Care
1
2015
117
0.030
 Why?
Antigens
1
1996
347
0.030
 Why?
Cohort Studies
2
2015
5960
0.030
 Why?
Respiratory Physiological Phenomena
1
1993
35
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1995
161
0.030
 Why?
ROC Curve
1
2015
614
0.030
 Why?
Sleep
1
2021
901
0.020
 Why?
Immunologic Memory
1
1996
366
0.020
 Why?
Chemokine CXCL10
2
2009
39
0.020
 Why?
Case-Control Studies
2
2013
3604
0.020
 Why?
Mice, Inbred BALB C
2
2006
1253
0.020
 Why?
Interdisciplinary Communication
1
2014
197
0.020
 Why?
Genotype
1
2018
1833
0.020
 Why?
Sex Factors
1
2019
2112
0.020
 Why?
Laparoscopy
1
1997
475
0.020
 Why?
Chemokines
2
2006
218
0.020
 Why?
Respiratory System
1
1993
149
0.020
 Why?
Cockroaches
1
2012
22
0.020
 Why?
Treatment Failure
1
1993
365
0.020
 Why?
Haptens
1
1992
21
0.020
 Why?
Healthcare Disparities
1
2019
727
0.020
 Why?
Cats
1
2012
228
0.020
 Why?
Patient Care
1
2013
118
0.020
 Why?
Vaccinia
1
2011
20
0.020
 Why?
Models, Theoretical
1
2015
582
0.020
 Why?
Reproducibility of Results
1
2019
3409
0.020
 Why?
Mice, Knockout
2
2011
3121
0.020
 Why?
Enterocolitis, Pseudomembranous
1
1991
28
0.020
 Why?
Receptors, Interferon
1
2011
60
0.020
 Why?
Dogs
1
2012
437
0.020
 Why?
Microbiota
1
2019
781
0.020
 Why?
Lung Diseases
1
1997
787
0.020
 Why?
Family
1
2015
679
0.020
 Why?
Fluorescent Antibody Technique
1
2011
370
0.020
 Why?
Predictive Value of Tests
1
2015
2115
0.020
 Why?
Antigens, Viral
1
2010
182
0.020
 Why?
Cell Line
2
2008
2882
0.020
 Why?
Chemokine CCL27
1
2009
1
0.020
 Why?
Health Care Costs
2
2003
427
0.020
 Why?
DNA Mutational Analysis
1
2010
406
0.020
 Why?
Incidence
1
1996
2879
0.020
 Why?
Mutation
2
2011
4089
0.020
 Why?
Age of Onset
1
2010
551
0.020
 Why?
Interferon-beta
1
2009
92
0.020
 Why?
Lung
1
2002
4109
0.020
 Why?
Skin Physiological Phenomena
1
2008
24
0.020
 Why?
Hospitalization
1
2019
2433
0.020
 Why?
Herpesvirus 1, Human
1
2009
84
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
112
0.020
 Why?
Glyceraldehyde-3-Phosphate Dehydrogenases
1
2007
11
0.020
 Why?
Fluticasone
1
2007
53
0.020
 Why?
Androstadienes
1
2007
76
0.020
 Why?
Chemokine CCL20
1
2006
5
0.020
 Why?
In Situ Hybridization
2
1998
319
0.020
 Why?
Thiazolidines
1
2006
13
0.020
 Why?
Toll-Like Receptor 3
1
2006
28
0.010
 Why?
Health Personnel
1
2013
748
0.010
 Why?
Vitis
1
2006
28
0.010
 Why?
Apoptosis
1
1995
2430
0.010
 Why?
Antigens, Differentiation, T-Lymphocyte
1
2006
100
0.010
 Why?
Europe
1
2006
412
0.010
 Why?
Analysis of Variance
1
2008
1306
0.010
 Why?
Obesity
1
2018
3077
0.010
 Why?
Antibodies, Viral
1
2009
672
0.010
 Why?
Product Surveillance, Postmarketing
1
2005
72
0.010
 Why?
Erythema
1
2004
28
0.010
 Why?
Neoplasms, Experimental
1
2005
173
0.010
 Why?
Genomics
1
2010
834
0.010
 Why?
Case Management
1
2004
67
0.010
 Why?
Antigens, Neoplasm
1
2006
271
0.010
 Why?
DNA, Viral
1
2006
358
0.010
 Why?
Inflammation Mediators
1
2006
509
0.010
 Why?
Collagen Type III
1
2003
18
0.010
 Why?
Rats
1
2012
5597
0.010
 Why?
Infant, Newborn
1
2015
6429
0.010
 Why?
Retreatment
1
2003
77
0.010
 Why?
Dendritic Cells
1
2006
499
0.010
 Why?
Genes, T-Cell Receptor beta
1
2002
23
0.010
 Why?
Collagen Type I
1
2003
147
0.010
 Why?
Base Sequence
1
2006
2190
0.010
 Why?
Immunoblotting
1
2002
300
0.010
 Why?
Insurance, Health, Reimbursement
1
2003
96
0.010
 Why?
Transforming Growth Factor beta1
1
2003
178
0.010
 Why?
Calcium
1
2008
1183
0.010
 Why?
Societies, Medical
1
2006
887
0.010
 Why?
Health Services
1
2003
115
0.010
 Why?
Administration, Oral
1
2004
847
0.010
 Why?
Immunophenotyping
1
2003
322
0.010
 Why?
Biopsy, Needle
1
2002
183
0.010
 Why?
Cooperative Behavior
1
2004
465
0.010
 Why?
Chemotactic Factors, Eosinophil
1
2000
7
0.010
 Why?
Up-Regulation
1
2003
851
0.010
 Why?
Chemokine CCL11
1
2000
25
0.010
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
331
0.010
 Why?
Cell Adhesion Molecules
1
2001
178
0.010
 Why?
Transforming Growth Factor beta
1
2003
479
0.010
 Why?
Extracellular Matrix Proteins
1
2001
158
0.010
 Why?
Cell Differentiation
1
2008
2050
0.010
 Why?
Patient Satisfaction
1
2004
704
0.010
 Why?
Odds Ratio
1
2003
1075
0.010
 Why?
Drug Prescriptions
1
2002
284
0.010
 Why?
Receptors, Interleukin-5
1
1998
4
0.010
 Why?
Receptors, Interleukin-12
1
1998
6
0.010
 Why?
Receptors, Interleukin-4
1
1998
16
0.010
 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
1998
16
0.010
 Why?
Amino Acid Sequence
1
2002
2155
0.010
 Why?
Flow Cytometry
1
2002
1173
0.010
 Why?
Molecular Sequence Data
1
2002
2930
0.010
 Why?
Cell Movement
1
2002
965
0.010
 Why?
Models, Biological
1
2004
1821
0.010
 Why?
Retrospective Studies
2
2006
17066
0.010
 Why?
Colorado
1
2006
4564
0.010
 Why?
Respiratory Function Tests
1
1997
547
0.010
 Why?
Immunocompetence
1
1994
47
0.010
 Why?
Interleukin-5
1
1994
39
0.010
 Why?
Methacholine Chloride
1
1993
50
0.010
 Why?
Bronchial Provocation Tests
1
1993
47
0.010
 Why?
Fatal Outcome
1
1994
307
0.010
 Why?
Aerosols
1
1993
186
0.010
 Why?
Interleukin-8
1
1993
271
0.010
 Why?
Macrophage Activation
1
1993
193
0.010
 Why?
Administration, Inhalation
1
1993
574
0.010
 Why?
Bronchi
1
1993
267
0.010
 Why?
Cell Survival
1
1995
1098
0.010
 Why?
Enterotoxins
1
1991
89
0.010
 Why?
Macrophages, Alveolar
1
1993
368
0.010
 Why?
Immunoglobulins, Intravenous
1
1991
126
0.000
 Why?
Antibodies, Bacterial
1
1991
148
0.000
 Why?
Interleukin-1
1
1993
961
0.000
 Why?
Neoplasms
1
2005
2875
0.000
 Why?
Transcription, Genetic
1
1993
1496
0.000
 Why?
Boguniewicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (542) concept(s)
_
Co-Authors Expand Description
See all (10) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)